Moreover, when CCAT2 expression level was associated with classical multiple myeloma biomarkers such as IgA, β2MG, and HGB, the area under the curve (AUC) was significantly improved up to 0.974 (95% CI 0.958~0.990; p < 0.001). The gene discussed is CCAT2; the disease is AL amyloidosis.